These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 27162119)
1. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis. Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of c-met in canine mammary tumours. Chen YC; Chen YY; Liao JW; Chang SC Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270 [TBL] [Abstract][Full Text] [Related]
4. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors. Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511 [TBL] [Abstract][Full Text] [Related]
5. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time. Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Zuccari DA; Santana AE; Cury PM; Cordeiro JA Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours. Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145 [TBL] [Abstract][Full Text] [Related]
8. High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study. Carvalho MI; Pires I; Prada J; Raposo TP; Gregório H; Lobo L; Queiroga FL Vet Comp Oncol; 2017 Jun; 15(2):619-631. PubMed ID: 26792550 [TBL] [Abstract][Full Text] [Related]
9. Down-expression of klotho in canine mammary gland tumors and its prognostic significance. Chung H; Lee S; Kim GA; Kim WH PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743 [TBL] [Abstract][Full Text] [Related]
10. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study. Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of bcl-2, ER-alpha, caspase -3, -8, -9, PCNA and Ki-67 expressions in canine mammary carcinomas. Aydogan A; Ozmen O; Haligur M; Sipahi C; Ileri D; Haligur A Biotech Histochem; 2018; 93(4):286-292. PubMed ID: 29565181 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome. Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401 [TBL] [Abstract][Full Text] [Related]
13. Cellular proliferative and telomerase activity in canine mammary gland tumors. Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647 [TBL] [Abstract][Full Text] [Related]
14. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry. Zacchetti A; van Garderen E; Teske E; Nederbragt H; Dierendonck JH; Rutteman GR APMIS; 2003 Mar; 111(3):430-8. PubMed ID: 12752223 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases. Rasotto R; Berlato D; Goldschmidt MH; Zappulli V Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108 [TBL] [Abstract][Full Text] [Related]
16. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002). Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Löhr CV; Teifke JP; Failing K; Weiss E Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640 [TBL] [Abstract][Full Text] [Related]
19. Expression of autophagy-related protein Beclin-1 in malignant canine mammary tumors. Liu JL; Chang KC; Lo CC; Chu PY; Liu CH BMC Vet Res; 2013 Apr; 9():75. PubMed ID: 23578251 [TBL] [Abstract][Full Text] [Related]
20. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs. de Araújo MR; Campos LC; Ferreira E; Cassali GD J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]